dc.contributor.author | Cuadrado Lavín, Antonio | |
dc.contributor.author | Olmos Martínez, José Manuel | |
dc.contributor.author | Cifrián Martínez, José Manuel | |
dc.contributor.author | Giménez Poderos, Teresa | |
dc.contributor.author | Gandarillas González, Marco Antonio | |
dc.contributor.author | García Saiz, María del Mar | |
dc.contributor.author | Henar Rebollo, María | |
dc.contributor.author | Martínez Taboada, Víctor Manuel | |
dc.contributor.author | López Hoyos, Marcos | |
dc.contributor.author | Fariñas Álvarez, María del Carmen | |
dc.contributor.author | Crespo García, Javier | |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2021-04-22T13:34:54Z | |
dc.date.available | 2021-04-22T13:34:54Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1745-6215 | |
dc.identifier.uri | http://hdl.handle.net/10902/21420 | |
dc.format.extent | 4 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | BioMed Central | es_ES |
dc.rights | Attribution 4.0 International | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Trials
. 2020 Jun 3;21(1):472. | es_ES |
dc.subject.other | COVID-19 | es_ES |
dc.subject.other | Randomised Controlled Trial | es_ES |
dc.subject.other | Protocol | es_ES |
dc.subject.other | Healthcare Professionals | es_ES |
dc.subject.other | Chemoprophylaxis | es_ES |
dc.subject.other | Hydroxychloroquine | es_ES |
dc.title | Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlle | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://doi.org/10.1186/s13063-020-04400-4 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.1186/s13063-020-04400-4 | |
dc.type.version | publishedVersion | es_ES |